Cencora, Inc. (COR) Shares Outstanding: 0.19
Is Cencora, Inc.’s shares outstanding high or low?
Cencora, Inc.'s shares outstanding of 0.19 is in line with its 5-year average of 0.20, near the low end of its 5-year range (0.19–0.21).
1.19% below its 12-month average of 0.20.
COR Shares Outstanding Chart
COR Average Shares Outstanding Chart
COR Current vs Average Shares Outstanding Chart
COR Shares Outstanding Metrics
SHARES OUTSTANDING
0.19
SHARES OUTSTANDING AVG TTM
0.20
SHARES OUTSTANDING AVG 3Y
0.20
SHARES OUTSTANDING AVG 5Y
0.20
SHARES OUTSTANDING AVG 10Y
0.21
SHARES OUTSTANDING AVG 15Y
0.22
SHARES OUTSTANDING AVG 20Y
0.26
CURRENT VS TTM AVG
-1.19%
CURRENT VS 3Y AVG
-3.74%
CURRENT VS 5Y AVG
-4.37%
CURRENT VS 10Y AVG
-7.00%
CURRENT VS 15Y AVG
-12.85%
CURRENT VS 20Y AVG
-24.43%
Share Structure
Shares Outstanding
193.82M
Float Shares
N/A
Stock Price
$281.67
Market Cap
$54.8B
Annual Shares Outstanding History
| Year | Weighted Average Shares | YoY Change |
|---|---|---|
| 2025 | 193.82M | -2.36% |
| 2024 | 198.50M | -2.98% |
| 2023 | 204.59M | -1.86% |
| 2022 | 208.47M | +1.24% |
| 2021 | 205.92M | +0.55% |
| 2020 | 204.78M | -2.56% |
| 2019 | 210.16M | -3.54% |
| 2018 | 217.87M | -0.23% |
| 2017 | 218.38M | +2.91% |
| 2016 | 212.21M | -2.56% |
| 2015 | 217.79M | -4.21% |
| 2014 | 227.37M | -1.60% |
| 2013 | 231.07M | -8.64% |
| 2012 | 252.91M | -7.18% |
| 2011 | 272.47M | -3.47% |
| 2010 | 282.26M | -6.09% |
| 2009 | 300.57M | -6.45% |
| 2008 | 321.28M | -13.25% |
| 2007 | 370.36M | -9.67% |
| 2006 | 410.02M | -3.59% |
| 2005 | 425.26M | -4.94% |
| 2004 | 447.35M | +2.75% |
| 2003 | 435.38M | +3.73% |
| 2002 | 419.74M | +83.50% |
| 2001 | 228.74M | +10.93% |
| 2000 | 206.21M | +1.68% |
| 1999 | 202.79M | +6.34% |
| 1998 | 190.71M | -3.85% |
| 1997 | 198.35M | +8.95% |
| 1996 | 182.05M | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
Cencora, Inc. Shares Outstanding Formula & Definition
Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cencora, Inc. Shares Outstanding FAQ
- What is the shares outstanding for Cencora, Inc. (COR)?
- The shares outstanding for COR stock is 0.19.
- Is Cencora, Inc.'s shares outstanding high or low?
- Cencora, Inc.'s shares outstanding of 0.19 is in line with its 5-year average of 0.20, near the low end of its 5-year range (0.19–0.21).
- What is the TTM average shares outstanding for Cencora, Inc. (COR)?
- The TTM average shares outstanding for COR stock is 0.20.
- What is the 3Y average shares outstanding for Cencora, Inc. (COR)?
- The 3Y average shares outstanding for COR stock is 0.20.
- What is the 5Y average shares outstanding for Cencora, Inc. (COR)?
- The 5Y average shares outstanding for COR stock is 0.20.
- What is the 10Y average shares outstanding for Cencora, Inc. (COR)?
- The 10Y average shares outstanding for COR stock is 0.21.
- What is the 15Y average shares outstanding for Cencora, Inc. (COR)?
- The 15Y average shares outstanding for COR stock is 0.22.
- What is the 20Y average shares outstanding for Cencora, Inc. (COR)?
- The 20Y average shares outstanding for COR stock is 0.26.
Cencora, Inc. Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2025-09-30 | 0.19 |
| 2024-09-30 | 0.20 |
| 2023-09-30 | 0.20 |
| 2022-09-30 | 0.21 |
| 2021-09-30 | 0.21 |
| 2020-09-30 | 0.20 |
| 2019-09-30 | 0.21 |
| 2018-09-30 | 0.22 |
| 2017-09-30 | 0.22 |
| 2016-09-30 | 0.21 |
| 2015-09-30 | 0.22 |
| 2014-09-30 | 0.23 |
| 2013-09-30 | 0.23 |
| 2012-09-30 | 0.25 |
| 2011-09-30 | 0.27 |
| 2010-09-30 | 0.28 |
| 2009-09-30 | 0.30 |
| 2008-09-30 | 0.32 |
| 2007-09-30 | 0.37 |
| 2006-09-30 | 0.41 |
| 2005-09-30 | 0.43 |
| 2004-09-30 | 0.45 |
| 2003-09-30 | 0.44 |
| 2002-09-30 | 0.42 |
| 2001-09-30 | 0.23 |
| 2000-09-30 | 0.21 |
| 1999-09-30 | 0.20 |
| 1998-09-30 | 0.19 |
| 1997-09-30 | 0.20 |
| 1996-09-30 | 0.18 |
Related Metrics
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Robert Mauch